| Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 … R de la Torre, S de Sola, G Hernandez, M Farré, J Pujol, J Rodriguez, ... The Lancet Neurology 15 (8), 801-810, 2016 | 293 | 2016 |
| Potential role of olive oil phenolic compounds in the prevention of neurodegenerative diseases J Rodríguez-Morató, L Xicota, M Fitó, M Farré, M Dierssen, R De la Torre Molecules 20 (3), 4655-4680, 2015 | 267 | 2015 |
| Neutrophil hyperactivation correlates with Alzheimer's disease progression Y Dong, J Lagarde, L Xicota, H Corne, Y Chantran, T Chaigneau, ... Annals of neurology 83 (2), 387-405, 2018 | 123 | 2018 |
| A new cognitive evaluation battery for Down syndrome and its relevance for clinical trials S de Sola, R de la Torre, G Sánchez-Benavides, B Benejam, ... Frontiers in psychology 6, 708, 2015 | 81 | 2015 |
| Potential role of (-)-epigallocatechin-3-gallate (EGCG) in the secondary prevention of Alzheimer disease L Xicota, J Rodriguez-Morato, M Dierssen, R de la Torre Current drug targets 18 (2), 174-195, 2017 | 74 | 2017 |
| Multi-omics signature of brain amyloid deposition in asymptomatic individuals at-risk for Alzheimer's disease: The INSIGHT-preAD study L Xicota, F Ichou, FX Lejeune, B Colsch, A Tenenhaus, I Leroy, ... EBioMedicine 47, 518-528, 2019 | 44 | 2019 |
| Cannabis Users Show Enhanced Expression of CB1-5HT2A Receptor Heteromers in Olfactory Neuroepithelium Cells L Galindo, E Moreno, F López-Armenta, D Guinart, A Cuenca-Royo, ... Molecular neurobiology 55, 6347-6361, 2018 | 44 | 2018 |
| Ultrastructural and dynamic studies of the endosomal compartment in Down syndrome A Botté, J Lainé, L Xicota, X Heiligenstein, G Fontaine, A Kasri, I Rivals, ... Acta Neuropathologica Communications 8, 1-22, 2020 | 33 | 2020 |
| Semantic Verbal Fluency Pattern, Dementia Rating Scores and Adaptive Behavior Correlate With Plasma Aβ42 Concentrations in Down Syndrome Young Adults LD Hoyo, L Xicota, G Sánchez-Benavides, A Cuenca-Royo, S Sola, ... Frontiers in Behavioral Neuroscience 9, 301, 2015 | 32 | 2015 |
| Treatment with a sphingosine-1-phosphate analog inhibits airway remodeling following repeated allergen exposure H Karmouty-Quintana, S Siddiqui, M Hassan, K Tsuchiya, PA Risse, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 302 (8 …, 2012 | 32 | 2012 |
| A phase 1, randomized double-blind, placebo controlled trial to evaluate safety and efficacy of epigallocatechin-3-gallate and cognitive training in adults with Fragile X syndrome R de la Torre, S de Sola, M Farré, L Xicota, A Cuenca-Royo, J Rodriguez, ... Clinical nutrition 39 (2), 378-387, 2020 | 27 | 2020 |
| Effect of epigallocatechin gallate on the body composition and lipid profile of down syndrome individuals: Implications for clinical management L Xicota, J Rodríguez, K Langohr, M Fitó, M Dierssen, R de la Torre, ... Clinical nutrition 39 (4), 1292-1300, 2020 | 26 | 2020 |
| MDMA-induced indifference to negative sounds is mediated by the 5-HT2A receptor KPC Kuypers, R De La Torre, M Farre, N Pizarro, L Xicota, JG Ramaekers Psychopharmacology 235, 481-490, 2018 | 26 | 2018 |
| Multi-omics data integration methods and their applications in psychiatric disorders A Sathyanarayanan, TT Mueller, MA Moni, K Schueler, BT Baune, P Lio, ... European Neuropsychopharmacology 69, 26-46, 2023 | 24 | 2023 |
| VNTR-DAT1 and COMTVal158Met genotypes modulate mental flexibility and adaptive behavior skills in down syndrome L Del Hoyo, L Xicota, K Langohr, G Sánchez-Benavides, S De Sola, ... Frontiers in behavioral neuroscience 10, 193, 2016 | 17 | 2016 |
| Depressive mood ratings are reduced by MDMA in female polydrug ecstasy users homozygous for the l-allele of the serotonin transporter KPC Kuypers, R De La Torre, M Farré, L Xicota, ... Scientific reports 8 (1), 1061, 2018 | 12 | 2018 |
| Association of APOE-Independent Alzheimer Disease Polygenic Risk Score With Brain Amyloid Deposition in Asymptomatic Older Adults L Xicota, B Gyorgy, B Grenier-Boley, A Lecoeur, G Fontaine, F Danjou, ... Neurology 99 (5), e462-e475, 2022 | 7 | 2022 |
| Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review C Pisanu, G Severino, I De Toma, M Dierssen, P Fusar-Poli, M Gennarelli, ... European Neuropsychopharmacology 55, 112-157, 2022 | 7 | 2022 |
| Recommendations for pharmacotranscriptomic profiling of drug response in CNS disorders L Xicota, I De Toma, E Maffioletti, C Pisanu, A Squassina, BT Baune, ... European Neuropsychopharmacology 54, 41-53, 2022 | 6 | 2022 |
| Converting disease maps into heavyweight ontologies: general methodology and application to Alzheimer’s disease V Henry, I Moszer, O Dameron, L Vila Xicota, B Dubois, MC Potier, ... Database 2021, baab004, 2021 | 5 | 2021 |
Rafael de La Torre FornellDirector del Instituto del Hospital del Mar de Investigaciones (IMIM), Profesor de Toxicología Asociado a la UPFVerified email at upf.edu
